ISRCTN91411631
Completed
Not Applicable
Post-Operative Radiotherapy for Selected High Risk Rectal Adenocarcinoma
orthern and Yorkshire Clinical Trials and Research Unit (UK)0 sites0 target enrollmentAugust 19, 2002
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Colorectal cancer
- Sponsor
- orthern and Yorkshire Clinical Trials and Research Unit (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Histologically proven adenocarcinoma of the rectum
- •2\. Surgery at or below pelvic brim
- •3\. Curative operation, all macroscopic disease removed
- •4\. Aged \<80 years, 75 years if physically unfit
- •5\. No previous history of multiple abdominal or pelvic surgical procedures
- •6\. No evidence of small bowel descending into area of maximum dose of radiotherapy
- •7\. Adequate bone marrow function
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042)NL-OMON32223EORTC30
Recruiting
Phase 3
Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial (JCOG1916, J-PORT)pathological N2 non-small cell lung cancerJPRN-UMIN000042905Japan Clinical Oncology Group (JCOG)330
Completed
Phase 2
Preoperative radiotherapy in patients at very high risk of postoperative pancreatic fistula after pancreatoduodenectomy (FIBROPANC-1): a multicenter phase II study(pre)malignant tumors in periampular region10017990NL-OMON54875Academisch Medisch Centrum33
Recruiting
Not Applicable
Preoperative radiotherapy in patients at very high risk of postoperative pancreatic fistula after pancreatoduodenectomy (FIBROPANC): a multicenter phase II studyMalignant and premalignant periampullary tumors, excluding pancreatic adenocarcinoma.NL-OMON21296A33
Active, not recruiting
Phase 1
Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus post-operative external radiotherapy alone in pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10 prostatic carcinoma. A Phase III studyEUCTR2006-002772-17-FREuropean Organisation for Research and Treatment of Cancer86